Bayer Overview
- Year Founded
-
1863
- Status
-
Public
- Employees
-
94,245
- Stock Symbol
-
BAYN
- Investments
-
98
- Share Price
-
$21.78
- (As of Friday Closing)
Bayer General Information
Description
Bayer is a German healthcare and agriculture conglomerate. Healthcare provides close to half of the company's sales and includes pharmaceutical drugs as well as vitamins and other consumer healthcare products. The firm also has a crop science business that includes seeds, pesticides, herbicides, and fungicides, which was expanded through its 2018 acquisition of Monsanto.
Contact Information
Website
www.bayer.comCorporate Office
- Kaiser-Wilhelm-Allee 1
- 51373 Leverkusen
- Germany
Corporate Office
- Kaiser-Wilhelm-Allee 1
- 51373 Leverkusen
- Germany
Bayer Timeline
Bayer Stock Performance
As of 17-Jan-2025, Bayer’s stock price is $21.78. Its current market cap is $21.4B.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $21.78 | $21.35 | $19.25 - $36.09 | $21.4B | 4.22M | -$0.97 |
Bayer Financials Summary
As of 30-Sep-2024, Bayer has a trailing 12-month revenue of $50.7B.
|
In Thousands, USD |
TTM 30-Sep-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 | FY 2021 31-Dec-2021 |
|---|---|---|---|---|
| EV | 72,628,378 | 77,085,632 | 85,901,992 | 91,387,581 |
| Revenue | 50,685,912 | 51,546,827 | 53,347,142 | 52,116,906 |
| EBITDA | 9,570,234 | 4,600,985 | 11,048,144 | 8,347,028 |
| Net Income | (954,312) | (3,182,384) | 4,363,323 | 1,182,299 |
| Total Assets | 119,447,361 | 128,512,684 | 133,917,790 | 136,139,354 |
| Total Debt | 45,973,597 | 47,392,914 | 44,311,467 | 44,757,818 |
Bayer Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Bayer Comparisons
Industry
Financing
Details
Bayer Competitors (5)
One of Bayer’s 5 competitors is Novartis, a Corporation company based in Basel, Switzerland.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Novartis | Corporation | Basel, Switzerland | ||||
| GSK | Corporation | Middlesex, United Kingdom | ||||
| Merck | Corporation | Darmstadt, Germany | ||||
| Evogene (Drug Discovery) | Formerly VC-backed | Rehovot, Israel | ||||
| Syngenta | Corporation | Basel, Switzerland |
Bayer Patents
Bayer Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20250018109-A1 | System and method for syringe plunger engagement with an injector | Pending | 30-Sep-2024 | ||
| EP-4492324-A1 | Detection of artifacts in synthetic medical records | Pending | 12-Jul-2023 | ||
| JP-2025003405-A | Extended high dose regimen of vegf antagonist for the treatment of intraocular neovascular disease | Pending | 23-Jun-2023 | ||
| EP-4480491-A1 | Extended, high dose vegf antagonist regimens for treatment of angiogenic eye disorders | Pending | 23-Jun-2023 | ||
| US-20240404255-A1 | Generation of artificial contrast-enhanced radiological images | Pending | 05-Jun-2023 | G06V10/774 |
Bayer Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Bayer Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Bayer Investments & Acquisitions (98)
Bayer’s most recent deal was a Merger/Acquisition with Smart Earth Camelina. The deal was made on 10-Jan-2025.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Smart Earth Camelina | 10-Jan-2025 | Merger/Acquisition | Cultivation | ||
| Cara Care | 11-Dec-2024 | Merger/Acquisition | Application Software | ||
| EarthOptics | 19-Nov-2024 | Later Stage VC | Business/Productivity Software | ||
| HyTech Production (Canola Processing and Packaging Facility in Coaldale, Alberta) | 03-Oct-2024 | Corporate Asset Purchase | Buildings and Property | ||
| Guardian Agriculture | 02-Oct-2024 | Later Stage VC | Other Hardware |
Bayer ESG
Risk Overview
Risk Rating
Updated November, 15, 2024
26.65 | Med Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 15,104
Rank
Percentile
Pharmaceuticals
Industry
of 851
Rank
Percentile
Pharmaceuticals
Subindustry
of 424
Rank
Percentile
Bayer Exits (24)
Bayer’s most recent exit was on 06-Jan-2021 from Senti Bio. The exit was categorized as with 21 buyers.
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Senti Bio | 06-Jan-2021 | Completed |
|
||
| Wellthy Therapeutics | 13-Apr-2020 | Completed |
|
||
| Plant Response | 26-Nov-2019 | Completed |
|
||
| Vindara | 02-Jul-2018 | Completed |
|
||
| Aparito | 01-Jan-2018 | Early Stage VC | Completed |
|
Affiliates
Subsidiaries (37)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Exolon Group | Munich, Germany | 2019 | |
| KaNDy Therapeutics | Stevenage, United Kingdom | 2017 | |
| BlueRock Therapeutics | Cambridge, MA | 2016 | |
| BrainVectis | Paris, France | 2015 | |
| Leaps by Bayer | Leverkusen, Germany | 2015 |
Bayer FAQs
-
When was Bayer founded?
Bayer was founded in 1863.
-
Where is Bayer headquartered?
Bayer is headquartered in Leverkusen, Germany.
-
What is the size of Bayer?
Bayer has 94,245 total employees.
-
What industry is Bayer in?
Bayer’s primary industry is Conglomerates.
-
Is Bayer a private or public company?
Bayer is a Public company.
-
What is Bayer’s stock symbol?
The ticker symbol for Bayer is BAYN.
-
What is the current stock price of Bayer?
As of 17-Jan-2025 the stock price of Bayer is $21.78.
-
What is the current market cap of Bayer?
The current market capitalization of Bayer is $21.4B.
-
What is Bayer’s current revenue?
The trailing twelve month revenue for Bayer is $50.7B.
-
Who are Bayer’s competitors?
Novartis, GSK, Merck, Evogene (Drug Discovery), and Syngenta are competitors of Bayer.
-
What is Bayer’s annual earnings per share (EPS)?
Bayer’s EPS for 12 months was -$0.97.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
